When did Neuronetics report Q2 2025 earnings?

Neuronetics (STIM) reported Q2 2025 earnings on August 5, 2025 before market open.

What were Neuronetics's Q2 2025 revenue and EPS?

Neuronetics reported revenue of $38.1M and eps of $-0.15 for Q2 2025.

Did Neuronetics beat estimates in Q2 2025?

Revenue beat the consensus estimate of $37.8M by $262.0K. EPS missed the consensus estimate of $-0.08 by $0.07.

How did Neuronetics's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 131.7% from $16.5M a year earlier and eps grew 54.5% from $-0.33.

Where can I find Neuronetics's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001558370-25-010180) directly on SEC EDGAR. The filing index links above go to sec.gov.

Neuronetics STIM Q2 2025 earnings

Reported August 5, 2025 · Before market open

Revenue$38.1MBeat by $262.0K

EPS-$0.15Miss by $0.07

Revenue estimate$37.8M

EPS estimate-$0.08

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$40.2M

EPS estimate-$0.11

Financials

Q2 2025

Income statement

See full

Revenue$38.1M+132%

Gross profit$17.8M+45.8%

Operating income-$8.1M+5.3%

Net income-$10.1M-2.9%

EPS (diluted)-$0.15+54.5%

Balance sheet

See full

Cash & equivalents$11.0M-74.3%

Total debt$80.7M+28.8%

Total equity$27.1M+40.0%

Total assets$134.7M+39.1%

Cash flow

See full

Operating cash flow-$3.5M+29.5%

CapEx$252.0K-59.1%

Free cash flow-$3.8M+32.7%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$233M+339%

Enterprise value$302.69M+314%

P/S2.1×+1.4×

Profitability

See full

Gross margin56.2%-17.1pp

Operating margin-34.4%-4.1pp

Net margin-43.9%-1.1pp

FCF margin-31.9%-5.3pp

Returns & leverage

See full

Return on equity-209.7%-2,425pp

Debt / equity3×-0.3×

Current ratio2×-0.6×

Segments

By product

See full

Clinic Revenue$23.0M+1,972%

Treatment Sessions$11.1M-6.3%

Neuro Star Advanced Therapy System$3.6M-8.9%

By segment

See full

Medical Device$38.1M+132%

By geography

See full

Non Us$452.0K+41.3%

Versus estimates

Revenue

Q1 2026$34.5MBeat by $286.0K Q4 2025$41.8MBeat by $1.1M Q3 2025$37.3MMiss by $549.0K

Q2 2025$38.1MBeat by $262.0K

Q1 2025$32.0MMiss by $4.6M Q4 2024$22.5MMiss by $6.3M

Diluted EPS

Q1 2026-$0.16Beat by $0.01 Q4 2025-$0.10Beat by $0.02 Q3 2025-$0.13Miss by $0.01

Q2 2025-$0.15Miss by $0.07

Q1 2025-$0.21Miss by $0.08 Q4 2024-$0.33Miss by $0.07

Ask the moment Neuronetics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Neuronetics report Q2 2025 earnings?: Neuronetics (STIM) reported Q2 2025 earnings on August 5, 2025 before market open.
What were Neuronetics's Q2 2025 revenue and EPS?: Neuronetics reported revenue of $38.1M and eps of $-0.15 for Q2 2025.
Did Neuronetics beat estimates in Q2 2025?: Revenue beat the consensus estimate of $37.8M by $262.0K. EPS missed the consensus estimate of $-0.08 by $0.07.
How did Neuronetics's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 131.7% from $16.5M a year earlier and eps grew 54.5% from $-0.33.
Where can I find Neuronetics's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001558370-25-010180) directly on SEC EDGAR. The filing index links above go to sec.gov.